Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Mallinckrodt Completes Divestiture of Therakos® Business PR Newswire DUBLIN, Dec. 2, 2024 Net Proceeds to...
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome...
Mallinckrodt to Present at Jefferies London Healthcare Conference PR Newswire DUBLIN, Nov. 14, 2024 DUBLIN...
Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance PR...
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for...
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal...
Mallinckrodt to Report Earnings Results for Third Quarter 2024 PR Newswire DUBLIN, Oct. 24, 2024 DUBLIN, Oct...
Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals PR...
Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use®...
THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device...
Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance PR...
Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled...
Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million PR Newswire DUBLIN and...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지